Company Update LUPIN LTD. - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to Expand Access to Medication for COPD Patients.